![]() |
市场调查报告书
商品编码
1374795
全球腹股沟疝气器材市场 -2023-2030Global Inguinal Hernia Devices Market -2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
腹股沟疝气装置是用来促进疝气周围受伤组织癒合的医疗装置。这些设备用于腹股沟疝气修补术,这是一种将疝气隆起压回原位并加强腹壁薄弱部位的外科手术。腹股沟疝气装置通常由网状材料组成,并缝合、钉合或粘合在疝气周围的区域。
网状物中的孔允许组织生长到装置中,从而减少疝气復发或復发的机会。除了网状装置外,在腹股沟疝气修补手术中还可以使用缝线(缝线),有时还可以使用网状装置。
修復疝气的手术可以是开腹手术或腹腔镜手术,外科医师会确定哪种麻醉方式最适合病人。总的来说,腹股沟疝气装置是腹股沟疝气手术治疗的关键组成部分,它们可以帮助支撑受损组织并防止疝气復发。
腹股沟疝气修补术数量的增加是腹股沟疝气器材市场的主要驱动力。例如,根据美国外科医师学会2023 年报告,光是在美国每年就进行100 万例腹股沟疝气修补手术,全球估计每年进行超过2,000 万例此类手术,疝气修补术已成为最常进行的普通外科手术之一全球。
此外,该报告强调腹股沟疝气的发生率不断增加,显示对疝气修復方案的巨大需求。需求激增表明医疗设备製造商需要开发创新产品,例如腹部三维 (3D) 成像,使医生能够透过小切口进行手术,而不是传统开放性手术中的大切口,从而减少组织损伤、减少疼痛并加快患者术后恢復,从而满足对成功的疝气修復手术日益增长的需求。
与疝气设备相关的高成本以及监管机构的挑战可能是一个潜在的障碍,并对预测期内的全球腹股沟疝气设备市场产生重大影响。这些设备的高成本可能会限制欠发达地区获得治疗的机会,给医疗机构带来压力,并影响患者选择手术的决策。
严格的监管审批流程和合规成本可能会对希望进入市场或开发产品的公司造成障碍。持续疼痛、感染、疝气復发、沾黏、肠阻塞、补片相关问题等併发症可能会导致不满意,并需要额外的医疗介入。这不会影响医疗费用,但也会阻止一些人接受疝气修补手术。对于行业利益相关者来说,克服这些挑战对于促进市场成长至关重要。
Inguinal hernia devices are medical devices that are used to promote the healing of injured tissue around hernias. These devices are used in inguinal hernia repair, a surgical procedure that presses a hernia bulge back into position and reinforces the abdominal wall weakness. Inguinal hernia devices usually consist of mesh and are stitched, stapled, or glued across the area surrounding the hernia.
Pores in the mesh allow tissue to grow into the device, which reduces the chance of a hernia recurring or relapsing. In addition to mesh devices, sutures (stitches) and sometimes mesh may be utilized during inguinal hernia repair surgery.
The surgery to repair the hernia can be open or laparoscopic, and the surgeon will determine which type of anesthesia is best for the patient. Overall, inguinal hernia devices are a key component of the surgical treatment of inguinal hernias, and they can help to support damaged tissue and prevent the hernia from returning.
The rising number of inguinal hernia repairs is a major driver of the inguinal hernia device market. For instance, according to the American College of Surgeons 2023 report, 1 million inguinal hernia repairs are performed annually in the U.S. alone and a global estimate exceeding 20 million such surgeries each year, hernia repair has become one of the most often performed general surgical procedures globally.
Furthermore, this report emphasizes the increasing occurrence of inguinal hernias, indicating a huge demand for hernia repair options. This spike in demand indicates the need for medical device manufacturers to develop innovative products such as three-dimensional (3D) imaging of the abdomen allowed doctors to perform surgery through small incisions rather than the huge incisions linked with traditional open surgery, leading to less tissue damage, less pain, and faster postoperative recovery for patients and thereby fulfilling the rising need for successful hernia repair procedures.
The high cost associated with hernia devices and the challenges posed by regulatory bodies can be a potential barrier and have a significant impact on the global inguinal hernia device market over the forecast period. The high cost of these devices may limit access to treatment in under developed regions and put strain on healthcare facility and influence patients decision making when it comes to opting for surgery.
The strict regulatory approval processes and compliance costs can create obstacles for companies looking to enter the market or develop products. Complications such as persistent pain, infections, hernia recurrence, adhesions, bowel obstructions, mesh-related issuesand others can lead to dissatisfaction and necessitate additional medical interventions. This not affects healthcare costs but also discourages some individuals from undergoing hernia repair surgery. Overcoming these challenges is crucial for industry stakeholders in order to foster growth, in the market.
The global inguinal hernia device market is segmented based on type, product, age group, surgical procedure, end user and region.
The hernia mesh segment accounted for 44.2% and it is expected to be dominated during the forecast period. The segment holds a position, in the market due to its usage and effectiveness in inguinal hernia repair procedures. These meshes offer support to weakened abdominal walls reducing the chances of hernia recurrence. They are available in materials and designs catering to the needs of patients. Additionally, rise of minimal invasive procedures has led to popularity due increasing number of surgeries has led to a higher demand, for hernia meshes as they work well with these procedures.
The increasing funding for the development of advanced mesh will create a positive impact on the market. For instance, in August 2022, Deep Blue Medical Advances, a Durham company previously funded with more than $400,000 in North Carolina Biotechnology Center loans, has raised more than $7 million in venture capital to facilitate development with the commercialization of its T-Line Hernia Mesh product. This innovative device intends to eliminate a common source of failure in conventional mesh fixation, reinforce anchors, and improve hernia repair procedures.
Furthermore, in February 2022, Dolphin Mesh, manufactured in India by Futura Surgicare Pvt Ltd, launched a premium surgical mesh brand built for "tension-free" and laparoscopic hernia repairs. These meshes serve as crucial devices in surgeries that strengthens weakened areas, enable tissue ingrowth, and may be modified to meet individual surgical demands. Thus, owing to the above factors the segment is expected to dominate over the forecast period.
North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of hernia, product approvals and FDA clearance, collaboration with the key players, and others that will drive this region further during the forecast period.
For instance, in October 2022, Medtronic plc, a prominent global healthcare technology business, received approvals for its Hugo robotic-assisted surgery (RAS) system, expanding its market reach and indications globally. Particulary, Health Canada has received a license for general laparoscopic surgery use. These approvals bring up new options for minimally invasive surgery in Europe, North America, and Asia, making the benefits more accessible globally. These treatments range from simple to sophisticated and include cholecystectomy, inguinal hernia repair, gastric bypass, and lower anterior resection.
Furthermore, in June 2023, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, received the U.S. FDA approval for the Pre-Market Approval (PMA) of LiquiBandFix8 for use in hernia surgery. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. Thus, owing to the above factors the region is expected to dominate over the forecast period.
The COVID-19 pandemic has majorly impacted the market, as it has resulted in a significant decrease in the amount of elective hernia repairs, particularly incisional hernia surgery. For instance, according to British Journal of Surgery 2022 article, inguinal hernia is a common surgical disease in children, with a 6% to 16% frequency in preterm and low-birthweight infants. The COVID-19 pandemic impacted hospital services, but it also presented a unique opportunity to collect clinical outcomes for children with inguinal hernia who would face delays in operative therapy, including the chance of spontaneous resolution while awaiting operative repair.
During the COVID-19 pandemic, twenty-five UK pediatric surgical centers took part in observational research evaluating the therapy of inguinal hernia in infants under 6 months of age. The study discovered a substantial decrease in the frequency of inguinal hernia repairs performed during the pandemic compared to the same period in the previous year.
The major global players in the inguinal hernia devices market include: B Braun Melsungen AG, Johnson & Johnson, Sinolinks Medical Innovation, Inc., Beijing Biosis Healing Biological Technology Co.,Ltd, Betatech Medical, Medtronic, W. L. Gore & Associates, Inc., Dynamesh Inc., Cousin Biotech, Cook Medical and among others.
The global inguinal hernia devices market report would provide approximately 79 tables, 79 figures, and 185 Pages.
LIST NOT EXHAUSTIVE